Rare diseases
Investigational molecules
Locations
Back to Germany1 140 clinical trials in Hamburg, Germany across 19 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
GermanyA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
GermanyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GermanyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
GermanyStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
GermanyLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GermanyLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focusing on innovative treatments for metastatic prostate cancer, colorectal cancer, and breast cancer. Studies are evaluating new therapeutic combinations and targeted approaches for improved patient outcomes.
Comprehensive vaccine development programs targeting respiratory syncytial virus, cytomegalovirus, and meningococcal infections. Research focuses on both adult and pediatric populations.
Groundbreaking research in treating acute cerebral ischemic stroke with innovative therapies. Studies are evaluating functional outcomes and safety profiles of new therapeutic agents.
Clinical investigations addressing vaginal atrophy and contraceptive technologies. Research includes novel delivery systems and hormone-based treatments for postmenopausal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
